Cytosorbents
CTSO
#9855
Rank
NZ$75.25 M
Marketcap
NZ$1.20
Share price
-8.62%
Change (1 day)
-19.45%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$22.55 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.97 Million. In 2024 the company made an earning of -NZ$38.91 Million, an increase over its 2023 earnings that were of -NZ$50.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$22.55 Million-42.03%
2024 -NZ$38.91 Million-22.49%
2023 -NZ$50.2 Million-13.52%
2022 -NZ$58.04 Million34.04%
2021 -NZ$43.3 Million182.17%
2020 -NZ$15.35 Million-55.97%
2019 -NZ$34.85 Million14.17%
2018 -NZ$30.53 Million95.14%
2017 -NZ$15.65 Million-22.32%
2016 -NZ$20.14 Million39.1%
2015 -NZ$14.48 Million-12.89%
2014 -NZ$16.62 Million89%
2013 -NZ$8.8 Million26.65%
2012 -NZ$6.95 Million-26.02%
2011 -NZ$9.39 Million-288.45%
2010 NZ$4.97 M-4.17%
2009 NZ$5.19 M-287.19%
2008 -NZ$2.78 Million-47.12%
2007 -NZ$5.25 Million41.78%
2006 -NZ$3.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
NZ$95.01 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.36 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$5.59 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA